AstraZeneca is UK Based Pharmaceutical and Bio-Technology Company. They have done some advanced research on Oncology. In the fight against COVID-19, Astrazeneca is one among World Top 5 Companies which has done advanced phase of Covid-19 testing in collaboration with the University of Oxford and are launching Phase III trials. Headquarters is in UK.
AstraZeneca Product Sales split by Disease Area for year ending Dec-2021
AstraZeneca annual revenue was 44,351 million USD for year ending Dec-2022 and annual operating profit was 3,757 million USD and annual net income was 3,288 million USD for year ending Dec-2022.
AstraZeneca has 83,500 employees as on 2022 when compared to with 76,100 employees as on 2020 and 70,600 employees as on 2019.
AstraZeneca has total assets of 96,483 million USD as on Dec-2022 when compared to 66,729 million USD as on Dec-2020.